How Epstein–Barr Virus Drives Multiple Sclerosis: New Mechanisms and Therapeutic Lessons
MedComm · 2026-07 · 7 (7)
DOI: 10.1002/mco2.70835 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 19.06.2026. Verfasst von Dan Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Animal Science Chinese Academy of Agricultural Sciences Beijing China. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agricultural Science and Technology Innovation Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Institute of Animal Science Chinese Academy of Agricultural Sciences Beijing China.
- College of Veterinary Medicine Northwest A&F University Yangling China.
- College of Chemistry and Molecular Sciences Henan University Kaifeng China.
Förderung
- Agricultural Science and Technology Innovation Program
Zitieren
APA
Liu, D., Fan, W., & Jiao, P. (2026). How Epstein–Barr Virus Drives Multiple Sclerosis: New Mechanisms and Therapeutic Lessons. MedComm, 7(7). https://doi.org/10.1002/mco2.70835
Vancouver
Liu D, Fan W, Jiao P. How Epstein–Barr Virus Drives Multiple Sclerosis: New Mechanisms and Therapeutic Lessons. MedComm. 2026;7(7). doi:10.1002/mco2.70835
BibTeX
@article{Liu2026,
author = {Liu, Dan and Fan, Wenhui and Jiao, Pengtao},
title = {How Epstein–Barr Virus Drives Multiple Sclerosis: New Mechanisms and Therapeutic Lessons},
journal = {MedComm},
year = {2026},
volume = {7},
number = {7},
doi = {10.1002/mco2.70835}
}
EUVIMED